Amarin Corp Ads (AMRN) 2.91 $AMRN Amarin to Report

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amarin Corp Ads (AMRN) 2.91 $AMRN

Amarin to Report Second Quarter 2016 Results and Host Conference Call at 7:30 A.M. ET on August 4, 2016
Marketwired - Thu Jul 28, 6:00AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - July 28, 2016) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter 2016 financial results and provide an operational update on Thursday, August 4, at 7:30 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day.
AMRN: 2.91 (+0.26)

Coverage Initiated on Select Drug Manufacturers' Stocks
ACCESSWIRE - Fri Jul 15, 8:16AM CDT
LONDON, UK / ACCESSWIRE / July 15, 2016 / Active Wall St. announces the list of stocks for today's coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers - Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. See our complete notes on Ionis Pharma at:
UTHR: 125.08 (+4.07), AMRN: 2.91 (+0.26), DEPO: 19.32 (+0.35), IONS: 38.01 (+8.82)

Featured Research Report on Drug Manufacturers Stocks
ACCESSWIRE - Tue Jun 14, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers-Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:
UTHR: 125.08 (+4.07), AMRN: 2.91 (+0.26), DEPO: 19.32 (+0.35), IONS: 38.01 (+8.82)

Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides
Marketwired - Sat Jun 11, 10:00AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 11, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced additional data on Vascepa (icosapent ethyl) presented at the annual meeting of the American Diabetes Association (ADA) supporting its efficacy in reducing concentrations of potentially atherogenic lipoproteins (lipoproteins that could promote fat deposits in arteries) in patients with Type 2 diabetes and persistent high triglyceride (TG) levels despite statin therapy.
AMRN: 2.91 (+0.26)

Vascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific Sessions
Marketwire Canada - Mon Jun 06, 6:30AM CDT
BEDMINSTER, NJ AND DUBLIN, IRELAND--(Marketwired - June 06, 2016) -  Amarin Corporation plc (NASDAQ: AMRN) today announced that new data related to Vascepa® (icosapent ethyl) will be presented at the upcoming American Diabetes Association (ADA) 76th Scientific Sessions in New Orleans (June 10-14) and published as an abstract in the Diabetes® Abstract Book.
AMRN: 2.91 (+0.26)

Amarin (AMRN) Looks Good: Stock Adds 6.7% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:40AM CDT
Amarin Corporation plc (AMRN) saw its shares rise almost 7% in the last trading session.
ANIP: 61.06 (+0.46), AMRN: 2.91 (+0.26)

Amarin to Present at the Jefferies 2016 Global Healthcare Conference
Marketwire Canada - Wed Jun 01, 7:01AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 01, 2016) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at the Jefferies 2016 Global Healthcare Conference in New York City on Tuesday, June 7, 2016, at 8:00 a.m. ET.
AMRN: 2.91 (+0.26)

Amarin Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) (icosapent ethyl) Capsules
Marketwire Canada - Tue May 31, 12:30PM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 31, 2016) - Amarin Corporation plc (NASDAQ: AMRN) announced today that the U.S. Food and Drug Administration (FDA) has determined that Vascepa® (icosapent ethyl) capsules are eligible for five-year, new chemical entity (NCE), marketing exclusivity pursuant to the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. This determination provides Vascepa with the benefits of NCE exclusivity afforded by statute. NCE exclusivity for Vascepa runs from its date of FDA approval on July 26, 2012 and extends until July 26, 2017. The statutory 30-month stay triggered by patent litigation following generic application submissions permitted on July 26, 2016 would expire on January 26, 2020, seven-and-a-half years from FDA approval.
AMRN: 2.91 (+0.26)

Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With Very High Triglyceride Levels
Marketwired - Fri May 20, 9:50AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 20, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced the presentation of a poster at the annual meeting of the National Lipid Association (NLA) further characterizing the efficacy and safety of Vascepa® (icosapent ethyl) in women with very high triglyceride levels.
AMRN: 2.91 (+0.26)

Vascepa(R) (icosapent ethyl) and Eicosapentaenoic Acid (EPA) Data to Be Presented at National Lipid Association 2016 Scientific Sessions
Marketwire Canada - Wed May 11, 6:30AM CDT
BEDMINSTER, NJ AND DUBLIN, IRELAND--(Marketwired - May 11, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced that new data related to Vascepa® (icosapent ethyl) and eicosapentaenoic acid (EPA) will be presented at the upcoming National Lipid Association 2016 Scientific Sessions in New Orleans (May 19-22).
AMRN: 2.91 (+0.26)

Amarin Reports First Quarter 2016 Financial Results and Provides Update on Operations
Marketwire Canada - Thu May 05, 6:00AM CDT
Product Revenue up 63% Over Prior Year; REDUCE-IT Cardiovascular Outcomes Study Achieves Target Enrollment; Preparation for Interim Analysis by Independent Data Monitoring Committee Underway; Management to Host Conference Call at 8:00 a.m. ET Today
AMRN: 2.91 (+0.26)

Investor Calendar Invites You to the Amarin First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 5, 2016
ACCESSWIRE - Wed May 04, 3:05PM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / May 4, 2016 / Amarin Corporation plc (NASDAQ: AMRN) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Thursday, May 5, 2016 at 8:00 AM Eastern Time.
AMRN: 2.91 (+0.26)

Amarin to Report First Quarter 2016 Results and Host Conference Call on May 5, 2016
Marketwired - Thu Apr 28, 6:44AM CDT
Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's first quarter 2016 financial results and provide an operational update on Thursday, May 5, at 8:00 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day.
AMRN: 2.91 (+0.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 287

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 232

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 45

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 23

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 81

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 92

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 94

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 0

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading

Top 5 Most Recently Viewed Articles

TCL SunPower Global Teams Up with Energia Italia for Solar Expansion

Updated Category News Views 313

TCL SunPower Global and Energia Italia Join Forces TCL SunPower Global is thrilled to unveil a new strategic partnership with Energia Italia, designed to significantly enhance the availability of advanced solar technology. As a renowned distributor in the residential and commercial solar markets, Energia Italia will take on the responsibility of providing Italian...

Continue Reading
AHAM Challenges Colorado's Appliance Labeling in Court

Updated Category News Views 200

AHAM Takes Legal Action Against Appliance Labeling Law The Association of Home Appliance Manufacturers (AHAM) has filed a federal lawsuit in response to a new appliance labeling law in Colorado. This law specifically mandates that gas stoves display a warning label concerning alleged health risks. AHAM alleges that this directive infringes upon First Amendment rights,...

Continue Reading
Impact BioMedical Inc. Sets Price for Its Initial Public Offering

Updated Category News Views 63

Impact BioMedical Inc. Pricing for Initial Public Offering Announced Impact BioMedical Inc. (NYSE: IBO) has officially revealed the pricing details for its initial public offering, establishing itself as a significant presence in the healthcare and wellness sectors. The company plans to offer 1,500,000 shares of its common stock at a public offering price of $3.00 per...

Continue Reading
Local Bounti Navigates NYSE Compliance Notice, Eyes Growth

Updated Category News Views 151

Local Bounti Faces NYSE Compliance Challenge Local Bounti Corporation (NYSE: LOCL), a pioneer in innovative indoor agriculture, has recently received an important notice from the New York Stock Exchange (NYSE). The notice highlights that the company is currently not meeting certain listing standards set by the NYSE. This notification pertains to the Minimum Market...

Continue Reading
SCWorx Expands Partnership: Three-Year Renewal and Growth

Updated Category News Views 154

SCWorx Strengthens Healthcare Partnerships with Renewed Agreement New York, NY — In a significant move, SCWorx Corp. (NASDAQ: WORX), known for its innovative healthcare data management solutions, has successfully renewed its agreement with a vital healthcare partner for another three years. This decision marks a substantial endorsement of the value SCWorx delivers, as...

Continue Reading